In recent years, numerous patient decision aids (PtDA) have been developed to facilitate informed, value based decisions about treatment options [ 1].
The difference in uncertainty, informed, value clarity and effective decision subscores between the intervention and control groups remained statistically significant after adjusting for differences in age, education and gender.
Patient decision aids assist patients in making informed value-based choices by providing evidence-based information about a health condition, treatment options (including no-treatment), and potential benefits and harms, including risk numbers in different formats [ 25].
Our hypothesis is that Decision boxes will prepare clinicians to help their patients make informed, value-based decisions by giving the clinicians research-based information about the benefits and harms of various diagnostic, therapeutic, and preventive interventions, before they meet their patients.
And, not least, how can they make informed, value-for-money choices?
Patient decision aids (PtDA) are developed to facilitate informed, value-based decisions about health.
Our hypothesis is that Decision boxes will prepare clinicians to help patients make informed value-based decisions.
The ability to integrate risk assessment and decision support in real time allows for informed, value-driven, and patient-centered breast cancer risk reduction decisions.
Légaré et al. [ 20] proposed an interprofessional SDM model, in which the individual patient follows a coached process to make informed, value-based decisions in concert with an interprofessional healthcare team.
DECISION+2 has the potential to reduce antibiotics use for ARIs by priming physicians and patients to share decisional process and empowering patients to make informed, value-based decisions.
Health professionals must be mobilized to ensure that elderly people and their family caregivers participate actively in decision making about their care and to help them make informed value-based decisions [ 1- 4].
